DAIC's exclusive, specialized cardiology product comparison charts help with your purchasing decisions

Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product specifications from various vendors, offering a side-by-side, apples-to-apples comparison when making purchasing decisions? These charts can save hours of research, and offer links back to the websites of each vendor for additional information. The charts were created by DAIC by sending out a questionnaire to each of the vendors listed. 

January 25, 2024 — New research confirms what public health leaders have been fearing: the significant uptick in the cardiovascular disease (CVD) death rate that began in 2020 has continued.

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (

January 25, 2024 — The American College of Cardiology’s Cardiovascular Summit (CV Summit) will take place on February 1-3 in Washington, DC.

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease

You may not know 
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announced that an independent 

January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular diseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024, will be held Feb. 7-9 in Phoenix, Arizona.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now